LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $527,285 | -2.7% | 7,850 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $541,886 | +43.2% | 7,850 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $378,527 | +47.2% | 7,850 | +52.4% | 0.00% | 0.0% |
| Q4 2022 | $257,088 | +16.9% | 5,150 | -4.6% | 0.00% | 0.0% |
| Q3 2022 | $220,000 | +89.7% | 5,400 | +157.1% | 0.00% | – |
| Q2 2022 | $116,000 | +52.6% | 2,100 | 0.0% | 0.00% | – |
| Q1 2022 | $76,000 | -14.6% | 2,100 | +10.5% | 0.00% | – |
| Q4 2021 | $89,000 | – | 1,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |